Showing results (121-130 of 696) with videos related to
Sort By:
Pageof 70
Psychopharmacology|January 1, 1987
Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophreniaE Peselow, B Angrist, A Sudilovsky, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1986
Brain metabolism in patients with schizophrenia before and after acute neuroleptic administrationN D Volkow, J D Brodie, A P Wolf, et al.Journal of Clinical Psychopharmacology|June 1, 1989
Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic childrenK D Meiselas, E K Spencer, R Oberfield, et al.The American Journal of Psychiatry|February 3, 2011
After GWAS: searching for genetic risk for schizophrenia and bipolar disorderElliot S Gershon, Ney Alliey-Rodriguez, Chunyu LiuDialogues in Clinical Neuroscience|March 4, 2015
Ethical and public policy challenges for pharmacogenomicsElliot S Gershon, Ney Alliey-Rodriguez, Kay GrennanArchives of General Psychiatry|January 1, 1975
Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidolB Shopsin, S Gershon, H Thompson, et al.Journal of Psychopharmacology (Oxford, England)|February 1, 2012
Reduction of dyskinesias and psychiatric disability with clozapine over different time coursesN C Moore, P A Lewitt, S GershonScience (New York, N.Y.)|February 7, 1975
Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinolB Hine, E Friedman, M Torrelio, et al.The American Journal of Psychiatry|September 1, 1993
Vitamin E treatment of tardive dyskinesiaL A Adler, E Peselow, J Rotrosen, et al.Pageof 70